Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research

被引:51
作者
Coyne, K. S. [1 ]
Sexton, C. C.
Kopp, Z. [2 ]
Chapple, C. R. [3 ]
Kaplan, S. A. [4 ]
Aiyer, L. P. [2 ]
Symonds, T. [5 ]
机构
[1] United BioSource Corp, Ctr Hlth Outcomes Res, Bethesda, MD 20814 USA
[2] Pfizer Inc, New York, NY USA
[3] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
[4] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA
[5] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England
关键词
BENIGN PROSTATIC HYPERPLASIA; ICSMALE QUESTIONNAIRE; ICS-BPH; INCONTINENCE; INDEX; EXPERIENCE; IMPACT; SCORE; MEN;
D O I
10.1111/j.1742-1241.2010.02450.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Aims: Understanding the patient's experience and symptom descriptions is critical to assess outcomes. Thus, there is a need for qualitative research to better understand how patients describe their symptoms and treatment expectations. Methods: Eight focus groups were conducted in two research phases: Phase 1 focused on eliciting patient's descriptions of urinary symptoms, and Phase 2 assessed patient perspectives on treatment outcomes. Participants with a range of lower urinary tract symptoms (LUTS) were recruited from urology clinics and community settings in the United States. All interviews were audio recorded and transcribed. Content and descriptive analyses were performed. Results: A total of 33 men and 30 women participated. Mean ages for men and women were 55 and 61 in Phase 1, and 57 and 61 in Phase 2, respectively. About 73% of participants were white people, and most had a high school education or greater. A wide range of LUTS were emergently described, and the words, concepts and phrases were generally similar across groups. Most participants identified with the word 'bother', and thought it was important to assess both the frequency and bother of each symptom. Reasons for seeking care included symptom bother and fears about cancer and bladder infections. Most participants thought that a 50% improvement in a single symptom or group of symptoms would be a meaningful treatment outcome. Conclusion: This qualitative research provides a better understanding on how men and women describe their LUTS and their perspectives on treatment outcomes. This research can be used to inform the development of a new LUTS outcomes' tool.
引用
收藏
页码:1260 / 1278
页数:19
相关论文
共 19 条
  • [1] The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society (Reprinted from Neurourology and Urodynamics, vol 21, pg 167-178, 2002)
    Abrams, P
    Cardozo, L
    Fall, M
    Griffiths, D
    Rosier, P
    Ulmsten, U
    Van Kerrebroeck, P
    Victor, A
    Wein, A
    [J]. UROLOGY, 2003, 61 (01) : 37 - 49
  • [2] [Anonymous], 2009, Guidance for Industry End-of-Phase 2A Meetings
  • [3] USING REPEATED-MEASURES OF SYMPTOM SCORE, UROFLOWMETRY AND PROSTATE-SPECIFIC ANTIGEN IN THE CLINICAL MANAGEMENT OF PROSTATE DISEASE
    BARRY, MJ
    GIRMAN, CJ
    OLEARY, MP
    WALKERCORKERY, ES
    BINKOWITZ, BS
    COCKETT, ATK
    GUESS, HA
    HOLTGREWE, HL
    MCCONNELL, JD
    SIHELNIK, SA
    MCLEOD, M
    WINFIELD, HN
    WILLIAMS, R
    [J]. JOURNAL OF UROLOGY, 1995, 153 (01) : 99 - 103
  • [4] Filling and voiding symptoms in the American Urological Association symptom index: The value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia
    Barry, MJ
    Williford, WO
    Fowler, FJ
    Jones, KM
    Lepor, H
    [J]. JOURNAL OF UROLOGY, 2000, 164 (05) : 1559 - 1564
  • [5] THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA
    BARRY, MJ
    FOWLER, FJ
    OLEARY, MP
    BRUSKEWITZ, RC
    HOLTGREWE, HL
    MEBUST, WK
    COCKETT, ATK
    BLAIVAS, JG
    WEIN, AJ
    [J]. JOURNAL OF UROLOGY, 1992, 148 (05) : 1549 - 1557
  • [6] BENIGN PROSTATIC HYPERPLASIA SPECIFIC HEALTH-STATUS MEASURES IN CLINICAL RESEARCH - HOW MUCH CHANGE IN THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX AND THE BENIGN PROSTATIC HYPERPLASIA IMPACT INDEX IS PERCEPTIBLE TO PATIENTS
    BARRY, MJ
    WILLIFORD, WO
    CHANG, YC
    MACHI, M
    JONES, KM
    WALKERCORKERY, E
    LEPOR, H
    [J]. JOURNAL OF UROLOGY, 1995, 154 (05) : 1770 - 1774
  • [7] The ICS-'BPH' study: The psychometric validity and reliability of the ICSmale questionnaire
    Donovan, JL
    Abrams, P
    Peters, TJ
    Kay, HE
    Reynard, J
    Chapple, C
    DeLaRosette, JJMCH
    Kondo, A
    [J]. BRITISH JOURNAL OF UROLOGY, 1996, 77 (04): : 554 - 562
  • [8] Donovan JL, 1999, BJU INT, V83, P243
  • [9] The impact of urge urinary incontinence on quality of life: Importance of patients' perspective and explanatory style
    DuBeau, CE
    Levy, B
    Mangione, CM
    Resnick, NM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (06) : 683 - 692
  • [10] *EMEA COMM PROP ME, 2004, REFL PAP REG GUID US